Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...

A common CV risk factor calculator for patients with HIV underestimates risk for Black patients and women, while risk for ...

According to data from amfAR, the Foundation for AIDS Research, about 1.3 million people are on HIV/AIDS treatment in Kenya, ...

The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...

The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...

The Trump administration's global aid freeze is threatening the lives of HIV-positive orphans at Nyumbani Children's Home in ...

Mississippi is grappling with some of the highest rates of sexually transmitted infections in the country, including ...

MadameNoire breaks down three common myths about HIV that persist today. Together, let's uncover the truth behind the stigma.

A recent survey conducted by the HIV Medicine Association identified barriers to implementation of long-acting injectables ...

David Furnish’s leadership at EJAF proves brands can do more than raise awareness —they can dismantle stigma and drive ...

A surge in the number of new HIV cases has been reported in the Swan Valley region, prompting Manitoba health officials to ...

Glenda Gray, program director of a research consortium, talked with STAT about the impact of the funding freeze on an HIV ...